Systematic analysis of the association between gut flora and obesity through high-throughput sequencing and bioinformatics approaches

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Chiu, Chih Min ^a   Huang, Wei Chih ^a   Weng, Shun Long ^a,b,c,d   Tseng, Han Chi ^e   Liang, Chao ^f   Wang, Wei Chi ^f   Yang, Ting ^a   Yang, Tzu Ling ^a   Weng, Chen Tsung ^f   Chang, Tzu Hao ^g   Huang, Hsien Da ^a,h  

^a NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^d MACKAY MEDICAL COLLEGE   (Taiwan)

^e Tseng Han Chi General Hospital   (Taiwan)

^f Health GeneTech Corporation   (Taiwan)

^g TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^h KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACINETOBACTER; ADULT; AGED; ALIIVIBRIO; ARTICLE; BACTEROIDES; BARNESIELLA; BIOINFORMATICS; BODY MASS; BUTYRICIMONAS; BUTYRIVIBRIO; CITROBACTER; CLOSTRIDIUM; COLLINSELLA; COMAMONAS; CONTROLLED STUDY; COPROCOCCUS; CRONOBACTER; DISEASE ASSOCIATION; ENTEROBACTER; ERWINIA; ESCHERICHIA; EUBACTERIUM; FAECALIBACTERIUM; FECES ANALYSIS; FEMALE; GEMMIGER; HALOMONAS; HIGH THROUGHPUT SEQUENCING; HUMAN; INTESTINE FLORA; LACHNOBACTERIUM; LACHNOSPIRACEAE; LECLERCIA; MAJOR CLINICAL STUDY; MALE; MARINOMONAS; MEGAMONAS; MICROBIAL COMMUNITY; MORGANELLA; NONHUMAN; OBESITY; OSCILLIBACTER; PECTINATUS; PHASCOLARCTOBACTERIUM; PREVOTELLA; PRINCIPAL COORDINATE ANALYSIS; PSEUDOALTEROMONAS; RAHNELLA; SERRATIA; SHEWANELLA; SHIGELLA; SUTTERELLA; SYNTROPHOCOCCUS; TAIWANESE; TATUMELLA; VEILLONELLA; BACTERIUM; BIODIVERSITY; BIOLOGY; BODY WEIGHT; CASE CONTROL STUDY; CLUSTER ANALYSIS; GASTROINTESTINAL TRACT; GENETICS; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

BIOLOGICAL MARKER;

ADULT; AGED; AGED, 80 AND OVER; BACTERIA; BIODIVERSITY; BIOLOGICAL MARKERS; BODY WEIGHT; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; FEMALE; GASTROINTESTINAL TRACT; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MIDDLE AGED; OBESITY; PRINCIPAL COMPONENT ANALYSIS; YOUNG ADULT;

EID: 84907414178     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/906168     Document Type: Article

References (70)

1. J. R. Goldsmith and R. B. Sartor, "The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications," Journal of Gastroenterology, vol. 49, no. 5, pp. 785-798, 2014.
2. J. Chen, X. He, and J. Huang, "Diet effects in gut microbiome and obesity," Journal of Food Science, vol. 79, no. 4, pp. R442-R451, 2014.
3. O. O. Erejuwa, S. A. Sulaiman, and M. S. Wahab, "Modulation of gut microbiota in the management of metabolic disorders: the prospects and challenges," International Journal of Molecular Sciences, vol. 15, no. 3, pp. 4158-4188, 2014.
4. G. L. Hold, M. Smith, C. Grange, E. R. Watt, E. M. El-Omar, and I. Mukhopadhya, "Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?" World Journal of Gastroenterology, vol. 20, no. 5, pp. 1192-1210, 2014.
5. M. Arumugam, J. Raes, E. Pelletier et al., "Enterotypes of the human gut microbiome," Nature, vol. 473, no. 7346, pp. 174-180, 2011.
6. G. D. Wu, J. Chen, C. Hoffmann et al., "Linking long-term dietary patterns with gut microbial enterotypes," Science, vol. 334, no. 6052, pp. 105-108, 2011.
7. J. Peterson, S. Garges, M. Giovanni et al., "The NIH human microbiome project," Genome Research, vol. 19, no. 12, pp. 2317-2323, 2009.
8. J. Qin, Y. Li, Z. Cai et al., "A metagenome-wide association study of gut microbiota in type 2 diabetes," Nature, vol. 490, no. 7418, pp. 55-60, 2012.
9. F. H. Karlsson, V. Tremaroli, I. Nookaew et al., "Gut metagenome in European women with normal, impaired and diabetic glucose control," Nature, vol. 498, no. 7452, pp. 99-103, 2013.
10. X. Zhang, D. Shen, Z. Fang et al., "Human gut microbiota changes reveal the progression of glucose intolerance," PLoS ONE, vol. 8, no. 8,Article ID e71108, 2013.
11. F. Karlsson, V. Tremaroli, J. Nielsen, and F. Backhed, "Assessing the human gut microbiota in metabolic diseases," Diabetes, vol. 62, no. 10, pp. 3341-3349, 2013.
12. A. Lyra, T. Rinttilä, J. Nikkilä et al., "Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification," World Journal of Gastroenterology, vol. 15, no. 47, pp. 5936-5945, 2009.
13. S. O. Noor, K. Ridgway, L. Scovell et al., "Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota," BMC Gastroenterology, vol. 10, article 134, 2010.
14. M. Rajilić-Stojanović, E. Biagi, H. G. H. J. Heilig et al., "Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome," Gastroenterology, vol. 141, no. 5, pp. 1792-1801, 2011.
15. Y. Zhu, T. Michelle Luo, C. Jobin, and H. A. Young, "Gut microbiota and probiotics in colon tumorigenesis," Cancer Letters, vol. 309, no. 2, pp. 119-127, 2011.
16. M. A. Hullar, A. N. Burnett-Hartman, and J.W. Lampe, "Gut microbes, diet, and cancer," Cancer Treatment and Research, vol. 159, pp. 377-399, 2014.
17. H. R. Hagland and K. Soreide, "Cellular metabolism in colorectal carcinogenesis: influence of lifestyle, gut microbiome and metabolic pathways," Cancer Letters, 2014.
18. K. Korpela, H. J. Flint, A. M. Johnstone et al., "Gut microbiota signatures predict host and microbiota responses to dietary interventions in obese individuals," PLoS One, vol. 9, no. 3, Article ID e90702, 2014.
19. B. A. Swinburn, G. Sacks, K. D. Hall et al., "The global obesity pandemic: shaped by global drivers and local environments,"The Lancet, vol. 378, no. 9793, pp. 804-814, 2011.
20. K. C. Portero McLellan, K. Wyne, E. T. Villagomez, and W. A. Hsueh, "Therapeutic interventions to reduce the risk of progression from prediabetes to type 2 diabetes mellitus,"Therapeutics and Clinical Risk Management, vol. 10, pp. 173-188, 2014.
21. A. Everard and P. D. Cani, "Diabetes, obesity and gut microbiota,"Best Practice and Research: Clinical Gastroenterology, vol. 27, no. 1, pp. 73-83, 2013.
22. J. A. Bell, M. Kivimaki, and M. Hamer, "Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies," Obesity Reviews, vol. 15, no. 6, pp. 504-515, 2014.
23. D. Nagakubo, M. Shirai, Y. Nakamura et al., "Prophylactic effects of the glucagon-like Peptide-1 analog liraglutide on hyperglycemia in a rat model of type 2 diabetes mellitus associated with chronic pancreatitis and obesity," Comparative Medicine, vol. 64, no. 2, pp. 121-127, 2014.
24. M. Kratz, T. Baars, and S. Guyenet, "The relationship between high-fat dairy consumption and obesity, cardiovascular, and metabolic disease," European Journal of Nutrition, vol. 52, no. 1, pp. 1-24, 2013.
25. G. M. Hinnouho, S. Czernichow, A. Dugravot et al., "Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: The Whitehall II Cohort Study," European Heart Journal, 2014.
26. K. A. Britton, J. M. Massaro, J. M. Murabito, B. E. Kreger, U. Hoffmann, and C. S. Fox, "Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality," Journal of the American College of Cardiology, vol. 62, no. 10, pp. 921-925, 2013.
27. E. E. Frezza, M. S. Wachtel, and M. Chiriva-Internati, "Influence of obesity on the risk of developing colon cancer," Gut, vol. 55, no. 2, pp. 285-291, 2006.
28. K. Nakamura, A. Hongo, J. Kodama, and Y. Hiramatsu, "Fat accumulation in adipose tissues as a risk factor for the development of endometrial cancer," Oncology Reports, vol. 26, no. 1, pp. 65-71, 2011.
29. M. Remely, E. Aumueller, D. Jahn, B. Hippe, H. Brath, and A. G. Haslberger, "Microbiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesity," Beneficial Microbes, vol. 5, no. 1, pp. 33-43, 2014.
30. R. E. Ley, P. J. Turnbaugh, S. Klein, and J. I. Gordon, "Microbial ecology: human gut microbes associated with obesity," Nature, vol. 444, no. 7122, pp. 1022-1023, 2006.
31. J. Shen, M. S. Obin, and L. Zhao, "The gut microbiota, obesity and insulin resistance," Molecular Aspects of Medicine, vol. 34, no. 1, pp. 39-58, 2013.
32. M. Nieuwdorp, P. W. Gilijamse, N. Pai, and L. M. Kaplan, "Role of the microbiome in energy regulation and metabolism,"Gastroenterology, vol. 146, no. 6, pp. 1525-1533, 2014.
33. P. J. Turnbaugh, F. Bäckhed, L. Fulton, and J. I. Gordon, "Diet-induced obesity is linked to marked but reversible alterations in themouse distal gut microbiome," Cell Host and Microbe, vol. 3, no. 4, pp. 213-223, 2008.
34. F. Bäckhed, H. Ding, T. Wang et al., "The gut microbiota as an environmental factor that regulates fat storage," Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 44, pp. 15718-15723, 2004.
35. P. J. Turnbaugh, M. Hamady, T. Yatsunenko et al., "A core gut microbiome in obese and lean twins," Nature, vol. 457, no. 7228, pp. 480-484, 2009.
36. J. Furet, L. Kong, J. Tap et al., "Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers," Diabetes, vol. 59, no. 12, pp. 3049-3057, 2010.
37. H. Zhang, J. K. DiBaise, A. Zuccolo et al., "Human gut microbiota in obesity and after gastric bypass," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 7, pp. 2365-2370, 2009.
38. Y. N. Yin, Q. F. Yu, N. Fu, X. W. Liu, and F. G. Lu, "Effects of four Bifidobacteria on obesity in high-fat diet induced rats," World Journal of Gastroenterology, vol. 16, no. 27, pp. 3394-3401, 2010.
39. R. E. Ley, "Obesity and the human microbiome," Current Opinion in Gastroenterology, vol. 26, no. 1, pp. 5-11, 2010.
40. The Human Microbiome Project Consortium, "Structure, function and diversity of the healthy human microbiome," Nature, vol. 486, no. 7402, pp. 207-214, 2012.
41. W. Pan, K. M. Flegal, H. Chang, W. Yeh, C. Yeh, and W. Lee, "Body mass index and obesity-related metabolic disorders in Taiwanese and US whites and blacks: Implications for definitions of overweight and obesity for Asians," The American Journal of Clinical Nutrition, vol. 79, no. 1, pp. 31-39, 2004.
42. A. Santacruz, M. C. Collado, L. García-Valdés et al., "Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women," British Journal of Nutrition, vol. 104, no. 1, pp. 83-92, 2010.
43. S. Xiao, N. Fei, X. Pang et al., "A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome," FEMS Microbiology Ecology, vol. 87, no. 2, pp. 357-367, 2014.
44. L. Rigsbee, R. Agans, V. Shankar et al., "Quantitative profiling of gut microbiota of children with diarrhea-predominant irritable bowel syndrome," The American Journal of Gastroenterology, vol. 107, no. 11, pp. 1740-1751, 2012.
45. N. Wu, X. Yang, R. Zhang et al., "Dysbiosis signature of fecal microbiota in colorectal cancer patients," Microbial Ecology, vol. 66, no. 2, pp. 462-470, 2013.
46. W. Chen, F. Liu, Z. Ling, X. Tong, and C. Xiang, "Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer," PLoS ONE, vol. 7, no. 6, Article ID e39743, 2012.
47. Q. Zhu, Z. Jin, W. Wu et al., "Analysis of the intestinal lumen microbiota in an animal model of colorectal cancer," PLoS ONE, vol. 9, no. 3, Article ID e90849, 2014.
48. OxA-23gene regions in isolates of Acinetobacter baumannii," Journal of Microbiology, Immunology and Infection, 2014.
49. H. Urbanczyk, J. C. Ast, M. J. Higgins, J. Carson, and P. V. Dunlap, "Reclassification of Vibrio fischeri, Vibrio logei, Vibrio salmonicida and Vibrio wodanis as Aliivibrio fischeri gen. nov., comb. nov., Aliivibrio logei comb. nov., Aliivibrio salmonicida comb. nov. and Aliivibrio wodanis comb. nov," International Journal of Systematic and Evolutionary Microbiology, vol. 57, part 12, pp. 2823-2829, 2007.
50. J. C. Ast, H. Urbanczyk, and P. V. Dunlap, "Multi-gene analysis reveals previously unrecognized phylogenetic diversity in Aliivibrio,"Systematic and Applied Microbiology, vol. 32, no. 6, pp. 379-386, 2009.
51. R. Beaz-Hidalgo, A. Doce, S. Balboa, J. L. Barja, and J. L. Romalde, "Aliivibrio finisterrensis sp. nov., isolated from Manila clam, Ruditapes philippinarum and emended description of the genus Aliivibrio," International Journal of Systematic and Evolutionary Microbiology, vol. 60, no. 1, pp. 223-228, 2010.
52. S. Yoshizawa, H. Karatani, M. Wada, A. Yokota, and K. Kogure, "Aliivibrio sifiae sp. nov., luminous marine bacteria isolated from seawater," Journal of General and Applied Microbiology, vol. 56, no. 6, pp. 509-518, 2010.
53. Y. S. Chen, Y. C. Liu, M. Y. Yen, J. H. Wang, S. R. Wann, and D. L. Cheng, "Skin and soft-tissue manifestations of Shewanella putrefaciens infection," Clinical Infectious Diseases, vol. 25, no. 2, pp. 225-229, 1997.
54. N. Vignier, M. Barreau, C. Olive et al., "Human infection with Shewanella putrefaciens and S. algae: report of 16 cases in Martinique and review of the literature," American Journal of Tropical Medicine and Hygiene, vol. 89, no. 1, pp. 151-156, 2013.
55. R. F. Boente, L. Q. Ferreira, L. S. Falcão et al., "Detection of resistance genes and susceptibility patterns in Bacteroides and Parabacteroides strains," Anaerobe, vol. 16, no. 3, pp. 190-194, 2010.
56. M. Sakamoto and Y. Benno, "Reclassification of Bacteroides distasonis, Bacteroides goldsteinii and Bacteroides merdae as Parabacteroides distasonis gen. nov., comb. nov., Parabacteroides goldsteinii comb. nov and Parabacteroides merdae comb. nov," International Journal of Systematic and Evolutionary Microbiology, vol. 56, part 7, pp. 1599-1605, 2006.
57. J. Xu, M. A. Mahowald, R. E. Ley et al., "Evolution of symbiotic bacteria in the distal human intestine.," PLoS Biology, vol. 5, no. 7, Article ID e156, 2007.
58. J. M. Clarke, D. L. Topping, C. T. Christophersen et al., "Butyrate esterified to starch is released in the human gastrointestinal tract," The American Journal of Clinical Nutrition, vol. 94, no. 5, pp. 1276-1283, 2011.
59. E. Sánchez, E. Donat, C. Ribes-Koninckx, M. Calabuig, and Y. Sanz, "Intestinal Bacteroides species associated with coeliac disease," Journal of Clinical Pathology, vol. 63, no. 12, pp. 1105-1111, 2010.
60. N. Becker, J. Kunath, G. Loh, and M. Blaut, "Human intestinal microbiota: characterization of a simplified and stable gnotobiotic rat model," Gut Microbes, vol. 2, no. 1, 2011.
61. N. Fei and L. Zhao, "An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice,"ISME Journal, vol. 7, no. 4, pp. 880-884, 2013.
62. A. Hejazi and F. R. Falkiner, "Serratia marcescens," Journal of Medical Microbiology, vol. 46, no. 11, pp. 903-912, 1997.
63. M. Patankar, S. Sukumaran, A. Chhibba, U. Nayak, and L. Sequeira, "Comparative in-vitro activity of cefoperazone-tazobactam and cefoperazone-sulbactam combinations against ESBL pathogens in respiratory and urinary infections," Journal of Association of Physicians of India, vol. 60, no. 11, pp. 22-24, 2012.
64. E. M. Carlisle, V. Poroyko, M. S. Caplan, J. Alverdy, M. J. Morowitz, and D. Liu, "Murine gut microbiota and transcriptome are diet dependent," Annals of Surgery, vol. 257, no. 2, pp. 287-294, 2013.
65. C. de Weerth, S. Fuentes, P. Puylaert, and W. M. de vos, "Intestinal microbiota of infants with colic: development and specific signatures," Pediatrics, vol. 131, no. 2, pp. e550-e558, 2013.
66. J. G. Caporaso, C. L. Lauber, W. A. Walters et al., "Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample," Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 1, pp. 4516-4522, 2011.
67. E. Pruesse, C. Quast, K. Knittel et al., "SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB," Nucleic Acids Research, vol. 35, no. 21, pp. 7188-7196, 2007.
68. R. C. Edgar, "Search and clustering orders of magnitude faster than BLAST," Bioinformatics, vol. 26, no. 19, pp. 2460-2461, 2010.
69. C. Lozupone, M. E. Lladser, D. Knights, J. Stombaugh, and R. Knight, "UniFrac: an effective distance metric for microbial community comparison," ISME Journal, vol. 5, no. 2, pp. 169-172, 2011.
70. M.Hall, E. Frank, G. Holmes, B. Pfahringer, P. Reutemann, and I. H. Witten, "The WEKA data mining software: an update,"SIGKDD Explorations, vol. 11, no. 1, pp. 10-18, 2009.